-
Je něco špatně v tomto záznamu ?
Acupuncture in migraine prophylaxis in Czech patients: an open-label randomized controlled trial
F. Musil, J. Pokladnikova, Z. Pavelek, B. Wang, X. Guan, M. Valis,
Jazyk angličtina Země Nový Zéland
Typ dokumentu časopisecké články
NLK
Directory of Open Access Journals
od 2009
Free Medical Journals
od 2005
PubMed Central
od 2005
Europe PubMed Central
od 2005
ProQuest Central
od 2005-01-01
Open Access Digital Library
od 2005-01-01
Open Access Digital Library
od 2009-01-01
Taylor & Francis Open Access
od 2005-12-01
Nursing & Allied Health Database (ProQuest)
od 2005-01-01
Health & Medicine (ProQuest)
od 2005-01-01
Psychology Database (ProQuest)
od 2005-01-01
ROAD: Directory of Open Access Scholarly Resources
od 2005
PubMed
29785113
DOI
10.2147/ndt.s155119
Knihovny.cz E-zdroje
- Publikační typ
- časopisecké články MeSH
Background: Adjuvant acupuncture for the symptomatic treatment of migraine reduces the frequency of headaches and may be at least similarly effective to treatment with prophylactic drugs. Methods: This article describes an open-label randomized controlled clinical trial with two groups: the intervention group (n=42) and the waiting-list control group (n=44). This study occurred at the Czech-Chinese Center for Traditional Chinese Medicine at the University Hospital Hradec Kralove between October 2015 and April 2017. Results: After 12 weeks of acupuncture, the number of migraine days was reduced by 5.5 and 2.0 days in the acupuncture and the waiting-list control groups, respectively, with a statistically significant inter-group difference of 2.0 migraine days (95% CI: -4 to -1). A significantly greater reduction in the number of migraine days per 4 weeks was reached at the end of the 6-month follow-up period in the acupuncture vs. control groups (Δ -4.0; 95% CI: -6 to -2). A statistically significant difference was observed in the number of responders to treatment (response defined as at least a 50% reduction in average monthly migraine day frequency) in the acupuncture vs waiting-list control groups (50% vs 27%; p<0.05) at the end of the intervention. A significantly greater percentage of responders to treatment was noted in the intervention vs control groups at the 6-month follow-up (81% vs 36%; p<0.001). Conclusion: Acupuncture can reduce symptoms and medication use, both short term and long term, as an adjuvant treatment in migraine prophylaxis in Czech patients.
Citace poskytuje Crossref.org
- 000
- 00000naa a2200000 a 4500
- 001
- bmc18024016
- 003
- CZ-PrNML
- 005
- 20180717085742.0
- 007
- ta
- 008
- 180709s2018 nz f 000 0|eng||
- 009
- AR
- 024 7_
- $a 10.2147/NDT.S155119 $2 doi
- 035 __
- $a (PubMed)29785113
- 040 __
- $a ABA008 $b cze $d ABA008 $e AACR2
- 041 0_
- $a eng
- 044 __
- $a nz
- 100 1_
- $a Musil, Frantisek $u Czech-Chinese Center for Traditional Chinese Medicine, University Hospital Hradec Kralove, Hradec Kralove, Czech Republic.
- 245 10
- $a Acupuncture in migraine prophylaxis in Czech patients: an open-label randomized controlled trial / $c F. Musil, J. Pokladnikova, Z. Pavelek, B. Wang, X. Guan, M. Valis,
- 520 9_
- $a Background: Adjuvant acupuncture for the symptomatic treatment of migraine reduces the frequency of headaches and may be at least similarly effective to treatment with prophylactic drugs. Methods: This article describes an open-label randomized controlled clinical trial with two groups: the intervention group (n=42) and the waiting-list control group (n=44). This study occurred at the Czech-Chinese Center for Traditional Chinese Medicine at the University Hospital Hradec Kralove between October 2015 and April 2017. Results: After 12 weeks of acupuncture, the number of migraine days was reduced by 5.5 and 2.0 days in the acupuncture and the waiting-list control groups, respectively, with a statistically significant inter-group difference of 2.0 migraine days (95% CI: -4 to -1). A significantly greater reduction in the number of migraine days per 4 weeks was reached at the end of the 6-month follow-up period in the acupuncture vs. control groups (Δ -4.0; 95% CI: -6 to -2). A statistically significant difference was observed in the number of responders to treatment (response defined as at least a 50% reduction in average monthly migraine day frequency) in the acupuncture vs waiting-list control groups (50% vs 27%; p<0.05) at the end of the intervention. A significantly greater percentage of responders to treatment was noted in the intervention vs control groups at the 6-month follow-up (81% vs 36%; p<0.001). Conclusion: Acupuncture can reduce symptoms and medication use, both short term and long term, as an adjuvant treatment in migraine prophylaxis in Czech patients.
- 655 _2
- $a časopisecké články $7 D016428
- 700 1_
- $a Pokladnikova, Jitka $u Czech-Chinese Center for Traditional Chinese Medicine, University Hospital Hradec Kralove, Hradec Kralove, Czech Republic. Faculty of Pharmacy in Hradec Kralove, Charles University, Hradec Kralove, Czech Republic.
- 700 1_
- $a Pavelek, Zbysek $u Department of Neurology, University Hospital Hradec Kralove, Hradec Kralove, Czech Republic.
- 700 1_
- $a Wang, Bo $u Shuguang Hospital Affiliated to Shanghai University of Traditional Chinese Medicine, Shanghai, People's Republic of China.
- 700 1_
- $a Guan, Xin $u Shuguang Hospital Affiliated to Shanghai University of Traditional Chinese Medicine, Shanghai, People's Republic of China.
- 700 1_
- $a Valis, Martin $u Department of Neurology, University Hospital Hradec Kralove, Hradec Kralove, Czech Republic.
- 773 0_
- $w MED00183034 $t Neuropsychiatric disease and treatment $x 1176-6328 $g Roč. 14, č. - (2018), s. 1221-1228
- 856 41
- $u https://pubmed.ncbi.nlm.nih.gov/29785113 $y Pubmed
- 910 __
- $a ABA008 $b sig $c sign $y a $z 0
- 990 __
- $a 20180709 $b ABA008
- 991 __
- $a 20180717090042 $b ABA008
- 999 __
- $a ind $b bmc $g 1316003 $s 1020934
- BAS __
- $a 3
- BAS __
- $a PreBMC
- BMC __
- $a 2018 $b 14 $c - $d 1221-1228 $e 20180510 $i 1176-6328 $m Neuropsychiatric disease and treatment $n Neuropsychiatr Dis Treat $x MED00183034
- LZP __
- $a Pubmed-20180709